Pictet Asset Management Holding Sa Vertex Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 791,458 shares of VRTX stock, worth $344 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
791,458
Previous 735,822
7.56%
Holding current value
$344 Million
Previous $328 Million
5.38%
% of portfolio
0.32%
Previous 0.35%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...